Covered recipient · General Payments record
TIFFANY MATTOX-RUBIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022
$232.81
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $232.81 | 17 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $131.87 | 11 |
| ITI, Inc. | $49.25 | 3 |
| IRONSHORE PHARMACEUTICALS INC. | $27.87 | 2 |
| Supernus Pharmaceuticals, Inc. | $23.82 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2022 | $232.81 | 17 |
Payment records · PY2022 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.91 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221689 | CMS |
| ABBVIE INC. | $6.25 | 04/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221691 | CMS |
| ABBVIE INC. | $9.23 | 05/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221693 | CMS |
| ABBVIE INC. | $19.63 | 05/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221695 | CMS |
| ABBVIE INC. | $2.86 | 06/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221697 | CMS |
| ABBVIE INC. | $21.45 | 06/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221699 | CMS |
| ABBVIE INC. | $12.22 | 06/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221701 | CMS |
| ABBVIE INC. | $11.94 | 07/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221703 | CMS |
| ABBVIE INC. | $20.98 | 08/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221705 | CMS |
| ABBVIE INC. | $4.63 | 09/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221707 | CMS |
| ABBVIE INC. | $9.77 | 09/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892221709 | CMS |
| Ironshore Pharmaceuticals Inc. | $13.57 | 06/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 958769651 | CMS |
| Ironshore Pharmaceuticals Inc. | $14.30 | 08/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 958769653 | CMS |
| ITI, Inc. | $13.68 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945888277 | CMS |
| ITI, Inc. | $15.83 | 05/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945888281 | CMS |
| ITI, Inc. | $19.74 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945888285 | CMS |
| Supernus Pharmaceuticals, Inc. | $23.82 | 07/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 953057551 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022
- Source files
- Dataset page · Bulk file · PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.